<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://qovigen.com/blogs/news</loc>
    <lastmod>2026-07-22T03:22:40-04:00</lastmod>
    <changefreq>weekly</changefreq>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/fat-loss</loc>
    <lastmod>2026-07-20T10:58:58-04:00</lastmod>
    <changefreq>weekly</changefreq>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/skin-support</loc>
    <lastmod>2026-07-20T10:58:58-04:00</lastmod>
    <changefreq>weekly</changefreq>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/anti-aging</loc>
    <lastmod>2026-07-20T10:58:58-04:00</lastmod>
    <changefreq>weekly</changefreq>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/muscle-growth</loc>
    <lastmod>2026-07-20T10:58:58-04:00</lastmod>
    <changefreq>weekly</changefreq>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/sexual-health</loc>
    <lastmod>2026-07-20T10:58:58-04:00</lastmod>
    <changefreq>weekly</changefreq>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/peptide-information</loc>
    <lastmod>2026-07-22T03:22:32-04:00</lastmod>
    <changefreq>weekly</changefreq>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/molecular-mechanisms-of-mots-c-in-the-regulation-of-lipid-%CE%B2-oxidation-during-exercise-stress</loc>
    <lastmod>2026-07-22T03:22:20-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_molecular-mechanisms-of-mots.webp?v=1784683125</image:loc>
      <image:title>Molecular Mechanisms of MOTS-c in the Regulation of Lipid β-Oxidation During Exercise Stress</image:title>
      <image:caption>Schematic of the proposed MOTS-c folate–AICAR–AMPK axis linking mitochondrial signaling to fatty-acid entry and β-oxidation in skeletal muscle; evidence is largely preclinical.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/mechanistic-basis-of-selank-associated-mood-stabilization-under-chronic-stress-conditions</loc>
    <lastmod>2026-07-22T03:22:21-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_mechanistic-basis-of-selank_e9c5268e-9efc-46a2-a0df-78e83e33ef2e.webp?v=1784685132</image:loc>
      <image:title>Mechanistic Basis of Selank-Associated Mood Stabilization Under Chronic Stress Conditions</image:title>
      <image:caption>Selank mechanism</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/what-are-emerging-biomarkers-for-monitoring-tesamorelin-s-metabolic-efficacy-responses</loc>
    <lastmod>2026-07-22T03:22:22-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_what-are-emerging-biomarkers.webp?v=1784683797</image:loc>
      <image:title>What Are Emerging Biomarkers For Monitoring Tesamorelin’s Metabolic Efficacy Responses?</image:title>
      <image:caption>The somatotropic cascade and three complementary biomarker tiers: IGF-1 confirms axis engagement, imaging quantifies tissue outcomes, and proteins, microRNAs, and enzymes report the mediators of change.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/how-does-nad-homeostasis-regulate-sirtuin-mediated-genomic-stability-in-chronic-disease-models</loc>
    <lastmod>2026-07-22T03:22:23-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_how-does-nad-homeostasis-reg.webp?v=1784683922</image:loc>
      <image:title>How Does NAD+ Homeostasis Regulate Sirtuin-Mediated Genomic Stability in Chronic Disease Models?</image:title>
      <image:caption>Schematic of how a shared intracellular NAD+ pool is divided among sirtuins, PARP1 and CD38, linking NAD+ supply to sirtuin-mediated DNA repair and genome maintenance (based on preclinical models).</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/what-molecular-pathways-are-most-commonly-linked-to-semax-associated-synaptic-modulation</loc>
    <lastmod>2026-07-22T03:22:24-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_what-molecular-pathways-are.webp?v=1784684040</image:loc>
      <image:title>What Molecular Pathways Are Most Commonly Linked to Semax-Associated Synaptic Modulation?</image:title>
      <image:caption>Proposed Semax signaling route in preclinical models: neurotrophin transcription and TrkB activation alongside broader transcriptome shifts (rodent and in vitro; not FDA approved).</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/what-experimental-evidence-explores-cyanocobalamin-s-role-in-red-blood-cell-formation</loc>
    <lastmod>2026-07-22T03:22:25-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_what-experimental-evidence-e.webp?v=1784684164</image:loc>
      <image:title>What Experimental Evidence Explores Cyanocobalamin’s Role in Red Blood Cell Formation?</image:title>
      <image:caption>Schematic of the cyanocobalamin-dependent methionine-synthase node linking folate cycling to thymidylate and DNA synthesis in erythroid precursors, as characterized in marrow and culture models.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/what-experimental-models-best-assess-melanotan-ii-effects-on-mc1r</loc>
    <lastmod>2026-07-22T03:22:25-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_what-experimental-models-bes.webp?v=1784684287</image:loc>
      <image:title>What Experimental Models Best Assess Melanotan II Effects on MC1R?</image:title>
      <image:caption>The MC1R cAMP-CREB-MITF-tyrosinase cascade that Melanotan II is used to probe, with the receptor-negative control that assigns the signal to MC1R.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/what-structural-features-enable-sermorelin-to-mimic-native-hypothalamic-peptides</loc>
    <lastmod>2026-07-22T03:22:26-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_what-structural-features-ena.webp?v=1784684412</image:loc>
      <image:title>What Structural Features Enable Sermorelin To Mimic Native Hypothalamic Peptides?</image:title>
      <image:caption>Two-part engagement model: the extracellular domain captures the helical body of GHRH(1&amp;ndash;29) while the peptide&apos;s N-terminal residues contact the transmembrane core to initiate Gs&amp;ndash;cyclic AMP signalling in pituitary somatotrophs.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/does-ghk-cu-regulate-antioxidant-defense-systems-at-the-molecular-level</loc>
    <lastmod>2026-07-22T03:22:27-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_does-ghk-cu-regulate-antioxi.webp?v=1784684539</image:loc>
      <image:title>Does GHK-Cu Regulate Antioxidant Defense Systems at the Molecular Level?</image:title>
      <image:caption>Reported mechanism: copper-bound GHK is studied as an upstream input to Nrf2-linked antioxidant enzyme expression and redox-active metal handling — evidence is preclinical.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/is-nad-deficiency-implicated-in-neurodegenerative-disease-progression-mechanisms</loc>
    <lastmod>2026-07-22T03:22:28-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_is-nad-deficiency-implicated.webp?v=1784684655</image:loc>
      <image:title>Is NAD⁺ Deficiency Implicated in Neurodegenerative Disease Progression Mechanisms?</image:title>
      <image:caption>Schematic of how declining neuronal NAD+ converges on mitochondrial, genomic, and proteostatic failure in preclinical models; evidence is rodent and in-vitro.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/what-molecular-pathways-link-tesamorelin-stimulation-to-sustained-igf-1-elevation</loc>
    <lastmod>2026-07-22T03:21:46-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_what-molecular-pathways-link_211d9d65-f603-48a9-ae84-c2a53506374c.webp?v=1784685861</image:loc>
      <image:title>What Molecular Pathways Link Tesamorelin Stimulation to Sustained IGF-1 Elevation?</image:title>
      <image:caption>Schematic of the proposed tesamorelin signaling axis: GHRH-receptor activation drives pulsatile growth hormone release, which engages hepatic JAK2–STAT5b to transcribe the IGF-1 gene, under somatostatin feedback.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/what-is-mots-c-and-how-is-it-classified-within-mitochondrial-derived-peptides</loc>
    <lastmod>2026-07-22T03:21:46-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_what-is-mots-c-and-how-is-it_4c2832cb-8b1b-4d41-81a9-fa5acf061d1a.webp?v=1784699770</image:loc>
      <image:title>What is MOTS-C, and how is it classified within mitochondrial-derived peptides?</image:title>
      <image:caption>Qovigen research diagram</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/what-scientific-studies-explain-ipamorelin-precision-versus-growth-hormone-peptides</loc>
    <lastmod>2026-07-22T03:21:47-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_what-scientific-studies-expl_4a17e230-ff91-4aa1-b60e-3cbbac1a54a0.webp?v=1784685877</image:loc>
      <image:title>What scientific studies explain Ipamorelin precision versus growth hormone peptides?</image:title>
      <image:caption>Schematic contrast of ipamorelin&apos;s selective GHSR-1a signaling versus the broader HPA-axis activation seen with legacy secretagogues, as reported in preclinical models.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/how-does-selank-modulate-gabaergic-activity-to-reduce-human-anxiety-levels</loc>
    <lastmod>2026-07-22T03:21:48-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_how-does-selank-modulate-gab.webp?v=1784686014</image:loc>
      <image:title>How Does Selank Modulate GABAergic Activity To Reduce Human Anxiety Levels?</image:title>
      <image:caption>Proposed model: Selank binds an accessory allosteric site on the GABA_A receptor, potentiating GABA-driven chloride flux rather than occupying the orthosteric GABA pocket, with a benzodiazepine site that may partially overlap.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/how-does-semax-potentially-affect-neural-circuit-stability-under-cognitive-load</loc>
    <lastmod>2026-07-22T03:21:49-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_how-does-semax-potentially-a.webp?v=1784686153</image:loc>
      <image:title>How Does Semax Potentially Affect Neural Circuit Stability Under Cognitive Load?</image:title>
      <image:caption>Reported Semax-associated BDNF/TrkB changes in rat hippocampus; magnitudes are modest and associative, not causal for circuit-level stability.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/how-does-retatrutide-affect-insulin-resistance-in-polycystic-ovary-syndrome</loc>
    <lastmod>2026-07-22T03:21:50-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_how-does-retatrutide-affect.webp?v=1784686276</image:loc>
      <image:title>How Does Retatrutide Affect Insulin Resistance In Polycystic Ovary Syndrome?</image:title>
      <image:caption>Hypothesized research pathway: retatrutide&apos;s GIP/GLP-1/glucagon agonism lowers hyperinsulinemia, which in preclinical models is linked to reduced ovarian androgen output — an extrapolated mechanism, not established in human PCOS.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/how-does-bpc-157-support-gut-lining-protection-in-ulcer-formation</loc>
    <lastmod>2026-07-22T03:21:51-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_how-does-bpc-157-support-gut.webp?v=1784686409</image:loc>
      <image:title>How Does BPC-157 Support Gut Lining Protection in Ulcer Formation?</image:title>
      <image:caption>Proposed BPC-157 mechanism in rodent ischemia models: collateral recruitment and NO/VEGF signaling associated with preserved mucosa — preclinical evidence only.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/how-does-vitamin-b12-affect-cognitive-performance-measures-in-research-trials</loc>
    <lastmod>2026-07-22T03:21:52-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_how-does-vitamin-b12-affect.webp?v=1784686516</image:loc>
      <image:title>How Does Vitamin B12 Affect Cognitive Performance Measures in Research Trials?</image:title>
      <image:caption>Vitamin B12 acts at two enzyme reactions &amp;mdash; methylation and myelin metabolism &amp;mdash; whose disruption is linked, in observational research, to structural brain measures.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/does-tb-500-enhance-cellular-migration-in-non-healing-diabetic-wound-models</loc>
    <lastmod>2026-07-22T03:21:52-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_does-tb-500-enhance-cellular.webp?v=1784686646</image:loc>
      <image:title>Does TB-500 Enhance Cellular Migration in Non-Healing Diabetic Wound Models?</image:title>
      <image:caption>Schematic of the actin, adhesion and matrix steps researchers examine when studying the thymosin beta-4 motif and directional cell migration; evidence is preclinical.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/how-does-ipamorelin-influence-pulsatile-growth-hormone-release-mechanisms-in-humans</loc>
    <lastmod>2026-07-22T03:21:53-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_how-does-ipamorelin-influenc.webp?v=1784686794</image:loc>
      <image:title>How Does Ipamorelin Influence Pulsatile Growth Hormone Release Mechanisms in Humans?</image:title>
      <image:caption>Schematic of how research models describe ipamorelin engaging GHS-R1a to amplify a hypothalamically gated growth hormone pulse; mechanism is largely preclinical.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/how-does-pt-141-address-sexual-dysfunction-linked-to-depressive-disorders</loc>
    <lastmod>2026-07-22T01:59:14-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_how-does-pt-141-address-sexu_4ad0b81f-1df9-48a5-bcbd-3cbd7af66678.webp?v=1784699651</image:loc>
      <image:title>How does PT-141 address sexual dysfunction linked to depressive disorders?</image:title>
      <image:caption>Qovigen research diagram</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/how-does-aod-9604-influence-lipolysis-without-altering-igf-1-signaling-pathways</loc>
    <lastmod>2026-07-22T03:20:48-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_how-does-aod-9604-influence.webp?v=1784687101</image:loc>
      <image:title>How Does AOD-9604 Influence Lipolysis Without Altering IGF-1 Signaling Pathways?</image:title>
      <image:caption>Schematic contrast: full-length GH drives GHR dimerization, JAK2/STAT5 and IGF-1 output, while the AOD-9604 fragment engages adipocyte β3-adrenergic expression and lipolysis without that receptor path — as described in rodent and in-vitro models.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/how-does-semaglutide-activate-glp-1-receptors-in-metabolic-research-models</loc>
    <lastmod>2026-07-22T03:20:48-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_how-does-semaglutide-activat_1fcab511-c5de-4837-9fec-b70b684ca4b7.webp?v=1784699667</image:loc>
      <image:title>How does Semaglutide activate GLP-1 receptors in metabolic research models?</image:title>
      <image:caption>Qovigen research diagram</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/how-does-orforglipron-influence-systemic-metabolic-pathways-in-research-models</loc>
    <lastmod>2026-07-22T03:20:49-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_how-does-orforglipron-influe.webp?v=1784687386</image:loc>
      <image:title>How does Orforglipron influence systemic metabolic pathways in research models?</image:title>
      <image:caption>Schematic of the reported orforglipron mechanism: small-molecule GLP-1R engagement biased toward cAMP–PKA–EPAC signaling, with downstream nodes studied across pancreatic, hepatic, adipose, and neural tissues in research models.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/how-does-melanotan-ii-modulate-mc1-signaling-in-pigmentation-research</loc>
    <lastmod>2026-07-22T03:20:50-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_how-does-melanotan-ii-modula.webp?v=1784687524</image:loc>
      <image:title>How does Melanotan II modulate MC1 signaling in pigmentation research?</image:title>
      <image:caption>Simplified view of the MC1R cascade studied in pigmentation research: Melanotan II binding is reported to raise cAMP, activate PKA, and drive MITF-dependent eumelanin synthesis. Evidence is strongest in vitro and in rodent models.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/how-does-sermorelin-influence-pituitary-signaling-pathways-in-endocrine-research</loc>
    <lastmod>2026-07-22T03:20:51-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_how-does-sermorelin-influenc_cb443f5f-b8b4-4929-98cc-127dfce5c422.webp?v=1784699683</image:loc>
      <image:title>How Does Sermorelin Influence Pituitary Signaling Pathways In Endocrine Research?</image:title>
      <image:caption>Qovigen research diagram</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/what-experimental-evidence-supports-ghk-cu-role-in-tissue-repair-signaling</loc>
    <lastmod>2026-07-22T03:20:52-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_what-experimental-evidence-s_2e376c93-bb26-42c7-b69f-09e836e18e80.webp?v=1784699762</image:loc>
      <image:title>What Experimental Evidence Supports GHK-Cu Role in Tissue Repair Signaling?</image:title>
      <image:caption>Qovigen research diagram</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/what-evidence-links-nad-depletion-with-cardiovascular-disease-progression</loc>
    <lastmod>2026-07-22T03:20:52-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_what-evidence-links-nad-depl.webp?v=1784687936</image:loc>
      <image:title>What Evidence Links NAD+ Depletion With Cardiovascular Disease Progression?</image:title>
      <image:caption>How experimental models trace NAD+ depletion through enzyme consumption and redox imbalance to maladaptive cardiac remodeling; evidence is largely preclinical and associative in humans.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/how-tesamorelin-regulates-lipid-metabolism-through-endocrine-crosstalk-mechanisms</loc>
    <lastmod>2026-07-22T03:20:54-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_how-tesamorelin-regulates-li.webp?v=1784688099</image:loc>
      <image:title>How Tesamorelin Regulates Lipid Metabolism Through Endocrine Crosstalk Mechanisms?</image:title>
      <image:caption>Tesamorelin drives pulsatile GH from the pituitary; GH and IGF-1 act across receptor-dense abdominal adipose, liver, and muscle, coupling lipolysis to hepatic and peripheral fatty-acid oxidation while pituitary feedback stays intact.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/what-evidence-shows-mots-c-modulates-glucose-homeostasis-in-various-conditions</loc>
    <lastmod>2026-07-22T03:20:55-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_what-evidence-shows-mots-c-m_2a9ac790-2645-42ad-b3c9-d490f275c63c.webp?v=1784699738</image:loc>
      <image:title>What Evidence Shows MOTS-C Modulates Glucose Homeostasis In Various Conditions?</image:title>
      <image:caption>Qovigen research diagram</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/what-evidence-shows-mots-c-modulates-glucose-homeostasis-in-various-conditions-1</loc>
    <lastmod>2026-07-22T03:22:32-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_what-evidence-shows-mots-c-m_eba363bc-dafe-4778-ab47-0a4757fb97a0.webp?v=1784688377</image:loc>
      <image:title>What Evidence Shows MOTS-C Modulates Glucose Homeostasis In Various Conditions?</image:title>
      <image:caption>Proposed mechanism studied in cell and rodent models: MOTS-c inhibits the folate one-carbon cycle, AICAR accumulates, AMPK is activated, and GLUT4-mediated glucose uptake is reported to increase; under stress the peptide also translocates to the nucleus.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/how-does-selank-regulate-behavior-via-central-nervous-system-pathways</loc>
    <lastmod>2026-07-22T03:22:33-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_how-does-selank-regulate-beh.webp?v=1784688504</image:loc>
      <image:title>How Does Selank Regulate Behavior via Central Nervous System Pathways?</image:title>
      <image:caption>Proposed time-dependent route by which Selank reshapes CNS gene expression and converges on GABAergic, monoaminergic, and plasticity pathways in animal models.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/how-does-semax-interact-with-acth-derived-pathways-to-support-neural-resilience</loc>
    <lastmod>2026-07-22T03:22:34-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_how-does-semax-interact-with_a2194587-3e42-44b7-b137-3de895ca2e40.webp?v=1784699675</image:loc>
      <image:title>How Does Semax Interact With ACTH-Derived Pathways To Support Neural Resilience?</image:title>
      <image:caption>Qovigen research diagram</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/how-does-vitamin-b12-modulate-methylation-pathways-across-cellular-research-models</loc>
    <lastmod>2026-07-22T03:22:35-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_how-does-vitamin-b12-modulat.webp?v=1784688907</image:loc>
      <image:title>How Does Vitamin B12 Modulate Methylation Pathways Across Cellular Research Models?</image:title>
      <image:caption>Schematic of vitamin B12 as the methionine synthase cofactor linking homocysteine remethylation to SAM and downstream DNA, RNA and histone methylation; based on preclinical and cell-model data.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/do-clinical-studies-show-that-tb-500-really-speeds-recovery-and-reduces-inflammation</loc>
    <lastmod>2026-07-22T03:22:36-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_do-clinical-studies-show-tha.webp?v=1784689054</image:loc>
      <image:title>Do Clinical Studies Show That TB-500 Really Speeds Recovery and Reduces Inflammation?</image:title>
      <image:caption>How thymosin &amp;beta;4 (TB-500) is proposed to act in tissue-repair research: actin sequestration drives cell migration, with downstream angiogenesis and matrix-remodeling branches (preclinical and in-vitro evidence).</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/does-pt-141-influence-neuroendocrine-pathways-to-enhance-libido-and-energy</loc>
    <lastmod>2026-07-22T01:59:27-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_does-pt-141-influence-neuroe.webp?v=1784689186</image:loc>
      <image:title>Does PT-141 Influence Neuroendocrine Pathways to Enhance Libido and Energy?</image:title>
      <image:caption>PT-141 acts on central melanocortin receptors (chiefly MC4R) in hypothalamic nodes that coordinate sexual reflex and motivation; its role in energy homeostasis is a separate metabolic function, not a demonstrated vitality effect.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/what-molecular-mechanisms-drive-aod-9604-neuroprotective-effects-in-obese-phenotypes</loc>
    <lastmod>2026-07-22T03:22:37-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_what-molecular-mechanisms-dr.webp?v=1784689314</image:loc>
      <image:title>What Molecular Mechanisms Drive AOD-9604 Neuroprotective Effects in Obese Phenotypes?</image:title>
      <image:caption>Hypothesized adipose-brain axis for AOD-9604: solid links are reported in rodent or mechanistic studies; dashed links remain inferred and untested for the peptide.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/what-do-clinical-trials-reveal-about-orforgliprons-long-term-impact-on-weight-loss</loc>
    <lastmod>2026-07-22T03:22:38-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_what-do-clinical-trials-reve.webp?v=1784689444</image:loc>
      <image:title>What Do Clinical Trials Reveal About Orforglipron&apos;s Long-Term Impact on Weight Loss?</image:title>
      <image:caption>Simplified schematic of how the oral non-peptide molecule orforglipron engages the GLP-1 receptor and the downstream pathways measured in clinical trials.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/new-research-on-semaglutide-s-cardiometabolic-impact-beyond-weight-loss</loc>
    <lastmod>2026-07-22T03:22:39-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_new-research-on-semaglutide_3062ee33-3c6f-408f-ae43-629e2bd65710.webp?v=1784699707</image:loc>
      <image:title>New Research on Semaglutide’s Cardiometabolic Impact Beyond Weight Loss</image:title>
      <image:caption>Qovigen research diagram</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/does-sermorelin-effectively-support-growth-hormone-and-regeneration-in-aging-adults</loc>
    <lastmod>2026-07-22T03:22:40-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_does-sermorelin-effectively.webp?v=1784689849</image:loc>
      <image:title>Does Sermorelin Effectively Support Growth Hormone and Regeneration in Aging Adults?</image:title>
      <image:caption>How a GHRH analog like sermorelin stimulates pituitary GH and downstream IGF-1 signaling, with evidence tiers noted for each reported effect.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/does-melanotan-ii-perform-in-sunless-tanning-research-and-what-are-the-associated-risks</loc>
    <lastmod>2026-07-22T03:21:04-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_does-melanotan-ii-perform-in.webp?v=1784690016</image:loc>
      <image:title>Does Melanotan II Perform in Sunless Tanning Research and What Are the Associated Risks?</image:title>
      <image:caption>Simplified MC1R signaling cascade by which Melanotan II is reported to bias melanocytes toward eumelanin synthesis in experimental models.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/what-scientific-evidence-supports-ghk-cu-s-role-in-skin-repair-and-anti-aging-processes</loc>
    <lastmod>2026-07-22T03:21:04-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_what-scientific-evidence-sup_a79cf583-435b-42ef-a3ac-aac8e45147bc.webp?v=1784699786</image:loc>
      <image:title>What Scientific Evidence Supports GHK-Cu’s Role in Skin Repair and Anti-Aging Processes?</image:title>
      <image:caption>Qovigen research diagram</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/what-evidence-shows-nad-supplements-impact-aging-and-support-cellular-health</loc>
    <lastmod>2026-07-22T03:21:05-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_what-evidence-shows-nad-supp.webp?v=1784690419</image:loc>
      <image:title>What Evidence Shows NAD+ Supplements Impact Aging and Support Cellular Health?</image:title>
      <image:caption>How researchers model NAD+ decline, its downstream effects on sirtuins, PARP1 and mitochondria, and precursor-driven repletion — with evidence level noted.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/what-evidence-supports-the-grow-h-peptide-blend-based-on-current-research</loc>
    <lastmod>2026-07-22T03:21:06-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_what-evidence-supports-the-g.webp?v=1784690560</image:loc>
      <image:title>What Evidence Supports the Grow-H Peptide Blend Based on Current Research?</image:title>
      <image:caption>Two receptor pathways — GHRH-R and GHS-R1a — converge on the somatotroph to drive pulsatile GH release; most supporting human data come from the DAC-conjugated version of CJC-1295.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/what-do-recent-clinical-findings-suggest-about-retatrutide-in-type-2-diabetes-management</loc>
    <lastmod>2026-07-22T03:21:07-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_what-do-recent-clinical-find.webp?v=1784690682</image:loc>
      <image:title>What Do Recent Clinical Findings Suggest About Retatrutide in Type 2 Diabetes Management?</image:title>
      <image:caption>How retatrutide, a single peptide, engages three incretin and glucagon receptors and the endpoints reported across research models and trials.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/what-evidence-supports-the-use-of-bpc-157-for-musculoskeletal-healing</loc>
    <lastmod>2026-07-22T03:21:08-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_what-evidence-supports-the-u.webp?v=1784690809</image:loc>
      <image:title>What Evidence Supports the Use of BPC-157 for Musculoskeletal Healing?</image:title>
      <image:caption>Proposed preclinical mechanism of BPC-157 in musculoskeletal repair models, converging on angiogenesis, fibroblast migration, and anabolic sensitisation; evidence is animal and in-vitro only.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/what-does-research-say-about-the-benefits-of-tb-500-for-tissue-repair-and-healing</loc>
    <lastmod>2026-07-22T03:21:09-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_what-does-research-say-about.webp?v=1784690921</image:loc>
      <image:title>What Does Research Say About the Benefits of TB-500 for Tissue Repair and Healing?</image:title>
      <image:caption>Proposed actin-based mechanism by which thymosin beta-4 and its LKKTETQ fragment (TB-500) influence cell migration, angiogenesis and inflammation in preclinical repair models.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/why-does-science-support-glow-peptide-for-skin-brightening-and-anti-aging</loc>
    <lastmod>2026-07-22T03:21:10-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_why-does-science-support-glo.webp?v=1784691053</image:loc>
      <image:title>Why Does Science Support Glow Peptide for Skin Brightening and Anti-Aging?</image:title>
      <image:caption>Simplified GHK-Cu mechanism in skin research models: copper binding, fibroblast matrix and antioxidant signaling, and gene-expression modulation — evidence largely in vitro and rodent.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/how-does-pt-141-revolutionize-treatments-for-sexual-health-and-desire</loc>
    <lastmod>2026-07-22T01:59:38-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_how-does-pt-141-revolutioniz_a703efcf-99da-4763-a4a9-3606e473facd.webp?v=1784699659</image:loc>
      <image:title>How Does PT-141 Revolutionize Treatments for Sexual Health and Desire?</image:title>
      <image:caption>Qovigen research diagram</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/how-does-tirzepatide-improve-insulin-sensitivity-in-research-models</loc>
    <lastmod>2026-07-22T03:21:11-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_how-does-tirzepatide-improve.webp?v=1784691459</image:loc>
      <image:title>How does Tirzepatide improve insulin sensitivity in research models?</image:title>
      <image:caption>Reported routes by which tirzepatide&apos;s dual receptor engagement is linked to insulin-sensitivity markers; adipose effects remain partly preclinical.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/how-does-aod-9604-deliver-clinically-backed-fat-loss-without-affecting-lean-muscle</loc>
    <lastmod>2026-07-22T03:20:55-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_how-does-aod-9604-deliver-cl.webp?v=1784691674</image:loc>
      <image:title>How Does AOD-9604 Deliver Clinically Backed Fat Loss Without Affecting Lean Muscle?</image:title>
      <image:caption>Reported preclinical mechanism: AOD-9604 promotes adipocyte lipolysis via beta-3 adrenergic receptor upregulation while leaving the GH-receptor/IGF-1 anabolic axis unengaged (rodent-model evidence).</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/how-effective-is-orforglipron-for-obesity-based-on-controlled-studies</loc>
    <lastmod>2026-07-22T03:20:56-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_how-effective-is-orforglipro.webp?v=1784691793</image:loc>
      <image:title>How Effective Is Orforglipron For Obesity Based On Controlled Studies?</image:title>
      <image:caption>Schematic of orforglipron as a small-molecule GLP-1 receptor agonist: oral absorption, high-affinity receptor binding, cAMP-biased signaling with minimal beta-arrestin recruitment, and the endpoint categories measured in controlled trials.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/how-do-semaglutide-trials-demonstrate-its-role-in-long-term-obesity-treatment</loc>
    <lastmod>2026-07-22T03:20:57-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_how-do-semaglutide-trials-de.webp?v=1784691909</image:loc>
      <image:title>How Do Semaglutide Trials Demonstrate Its Role in Long-Term Obesity Treatment?</image:title>
      <image:caption>Proposed appetite-mediated mechanism: GLP-1 receptor agonism lowers energy intake, with weight change contingent on continued dosing.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/what-evidence-supports-klows-impact-on-skin-elasticity-based-on-clinical-research</loc>
    <lastmod>2026-07-22T03:20:58-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_what-evidence-supports-klows.webp?v=1784692028</image:loc>
      <image:title>What Evidence Supports Klow&apos;s Impact on Skin Elasticity Based on Clinical Research?</image:title>
      <image:caption>How KLOW&apos;s four constituent peptides act on the dermal fibroblast and extracellular matrix to influence elasticity-linked markers, with the evidence level shown honestly.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/how-does-melanotan-ii-influence-melanin-production-in-scientific-skin-studies</loc>
    <lastmod>2026-07-22T03:20:58-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_how-does-melanotan-ii-influe.webp?v=1784692154</image:loc>
      <image:title>How Does Melanotan II Influence Melanin Production In Scientific Skin Studies?</image:title>
      <image:caption>Simplified schematic of the MC1R signalling cascade researchers use to explain Melanotan II-driven eumelanin synthesis in melanocytes.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/what-does-research-say-about-sermorelin-s-role-in-stimulating-natural-growth-hormone</loc>
    <lastmod>2026-07-22T03:20:59-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_what-does-research-say-about_9ebf0a74-6f92-4091-a900-47d708dd0088.webp?v=1784692162</image:loc>
      <image:title>What Does Research Say About Sermorelin’s Role in Stimulating Natural Growth Hormone?</image:title>
      <image:caption>How sermorelin, a GHRH(1-29) analog, engages the pituitary GHRH receptor and the Gs–cAMP–PKA cascade that drives pulsatile growth hormone release in experimental models.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/what-does-ghk-cu-do-for-skin-health-wrinkle-reduction-and-collagen-synthesis</loc>
    <lastmod>2026-07-22T03:21:00-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_what-does-ghk-cu-do-for-skin.webp?v=1784692301</image:loc>
      <image:title>What Does GHK-Cu Do for Skin Health, Wrinkle Reduction, and Collagen Synthesis?</image:title>
      <image:caption>Simplified research schematic: how GHK-Cu is described acting on dermal fibroblasts and extracellular-matrix turnover in preclinical models.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/how-nad-500mg-influences-cellular-damage-repair-and-longevity-in-human-studies</loc>
    <lastmod>2026-07-22T03:21:01-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_how-nad-500mg-influences-cel.webp?v=1784692435</image:loc>
      <image:title>How NAD+ 500mg Influences Cellular Damage Repair and Longevity in Human Studies?</image:title>
      <image:caption>NAD+ is a shared substrate consumed by sirtuins, PARPs, and CD38/CD157, which compete for the same finite pool; the NAMPT salvage pathway resynthesizes it, and net levels decline with age.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/what-are-the-key-findings-on-retatrutide-for-managing-obesity-and-metabolic-health</loc>
    <lastmod>2026-07-22T03:21:02-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_what-are-the-key-findings-on.webp?v=1784692570</image:loc>
      <image:title>What Are the Key Findings on Retatrutide for Managing Obesity and Metabolic Health?</image:title>
      <image:caption>How retatrutide&apos;s single peptide engages the GLP-1, GIP and glucagon receptors, and the metabolic effects reported in phase 2 research.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/what-research-says-regarding-bpc-157-healing-effects-on-the-gut-and-inflammation</loc>
    <lastmod>2026-07-22T03:21:03-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_what-research-says-regarding.webp?v=1784692698</image:loc>
      <image:title>What Research Says Regarding BPC 157 Healing Effects on the Gut and Inflammation?</image:title>
      <image:caption>Proposed NO-VEGF axis in BPC-157 gut research: eNOS/NO signaling drives VEGF-A/VEGFR2 angiogenesis and endothelial protection, supporting mucosal perfusion and repair; co-administered L-NAME weakens the response. Preclinical (rodent) mechanism.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/what-evidence-shows-tb-500-effectiveness-in-tendon-and-ligament-repair-post-injury</loc>
    <lastmod>2026-07-22T03:21:37-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_what-evidence-shows-tb-500-e.webp?v=1784692844</image:loc>
      <image:title>What Evidence Shows TB-500 Effectiveness in Tendon and Ligament Repair Post-Injury?</image:title>
      <image:caption>Proposed preclinical mechanism: TB-500/thymosin beta-4 sequesters G-actin, which is associated with cell migration, angiogenesis and reduced fibrosis in connective-tissue remodeling models. Evidence is preclinical only.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/are-clinical-trials-showing-grow-h-boosts-muscle-recovery-and-performance</loc>
    <lastmod>2026-07-22T03:21:38-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_are-clinical-trials-showing.webp?v=1784692973</image:loc>
      <image:title>Are Clinical Trials Showing Grow-H Boosts Muscle Recovery And Performance?</image:title>
      <image:caption>Mechanistic model of the Grow-H components: CJC-1295 (GHRH pathway) and ipamorelin (ghrelin/GHS-R1a pathway) converge on pituitary GH release and downstream IGF-1, with the step to recovery or performance shown as unestablished in humans for this blend.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/the-science-behind-glow-peptide-boosting-collagen-and-restoring-skins-natural-glow</loc>
    <lastmod>2026-07-22T03:21:39-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_the-science-behind-glow-pept.webp?v=1784693102</image:loc>
      <image:title>The Science Behind Glow Peptide Boosting Collagen and Restoring Skin&apos;s Natural Glow?</image:title>
      <image:caption>Proposed mechanism explored in cell and rodent models: GHK-Cu signals dermal fibroblasts to modulate collagen-gene expression and MMP activity — an in-vitro/preclinical hypothesis, not a human-proven effect.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/how-pt-141-supports-enhancing-sexual-desire-and-sperm-performance-in-clinical-trials</loc>
    <lastmod>2026-07-22T03:21:40-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_how-pt-141-supports-enhancin.webp?v=1784693221</image:loc>
      <image:title>How PT-141 Supports Enhancing Sexual Desire and Sperm Performance in Clinical Trials?</image:title>
      <image:caption>Simplified schematic of PT-141&apos;s central melanocortin mechanism; effects on sperm parameters are not established in the literature.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/peptide-information/peptide-purity</loc>
    <lastmod>2026-07-22T03:21:15-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_peptide-purity.webp?v=1784698510</image:loc>
      <image:title>Peptide Purity</image:title>
      <image:caption>A typical orthogonal workflow: reversed-phase HPLC estimates purity by peak area, while mass spectrometry confirms identity by matching observed to theoretical mass.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/peptide-information/research-peptides</loc>
    <lastmod>2026-07-22T03:21:16-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_research-peptides.webp?v=1784698667</image:loc>
      <image:title>Research Peptides</image:title>
      <image:caption>Most peptides act as signaling molecules: the peptide binds a specific cell-surface receptor — frequently a G-protein-coupled receptor — and that binding event triggers an intracellular response. This mechanism is documented in cell and animal models.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/peptide-information/peptide-bonds</loc>
    <lastmod>2026-07-22T03:21:17-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_peptide-bonds.webp?v=1784698796</image:loc>
      <image:title>Peptide Bonds</image:title>
      <image:caption>Two amino acids condense with loss of water to form the planar, partly double-bonded peptide (amide) linkage.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/peptide-information/peptide-solubility</loc>
    <lastmod>2026-07-22T03:21:18-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_peptide-solubility.webp?v=1784698924</image:loc>
      <image:title>Peptide Solubility</image:title>
      <image:caption>Decision framework for peptide reconstitution: estimate net charge from the sequence, always attempt sterile water first, then match solvent class to charge state — with an oxidation caveat for cysteine-, methionine- and tryptophan-containing peptides.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/peptide-information/american-made-peptides</loc>
    <lastmod>2026-07-22T03:21:19-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_american-made-peptides_a36d9e52-ca28-4e31-b020-17847e27e671.webp?v=1784699565</image:loc>
      <image:title>American Made Peptides</image:title>
      <image:caption>Qovigen research diagram</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/peptide-information/peptides-vs-proteins</loc>
    <lastmod>2026-07-22T03:21:20-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_peptides-vs-proteins.webp?v=1784699200</image:loc>
      <image:title>Peptides vs Proteins</image:title>
      <image:caption>From a single amino acid to a folded protein: peptide bonds link monomers into chains, with length and folding rising along the continuum.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/peptide-information/peptide-storage</loc>
    <lastmod>2026-07-22T03:22:29-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_peptide-storage.webp?v=1784698973</image:loc>
      <image:title>Peptide Storage</image:title>
      <image:caption>The principal chemical and physical degradation routes for peptides; cold, dark, dry storage slows each pathway to a different degree.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/peptide-information/peptide-purification</loc>
    <lastmod>2026-07-22T03:22:30-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_peptide-purification.webp?v=1784699104</image:loc>
      <image:title>Peptide Purification</image:title>
      <image:caption>How reversed-phase HPLC separates a crude synthetic peptide into a purified target fraction and related impurities.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/peptide-information/peptide-synthesis</loc>
    <lastmod>2026-07-22T03:22:31-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_peptide-synthesis.webp?v=1784699254</image:loc>
      <image:title>Peptide Synthesis</image:title>
      <image:caption>The repeating SPPS cycle: after anchoring, deprotection, coupling, and washing repeat once per residue before final cleavage releases the free peptide.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/peptide-information/intro-to-peptides</loc>
    <lastmod>2026-07-22T03:22:32-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_intro-to-peptides.webp?v=1784699521</image:loc>
      <image:title>Intro to Peptides</image:title>
      <image:caption>Peptide bond formation: a condensation reaction links the carboxyl group of one amino acid to the amino group of another, forming a -CO-NH- amide bond and releasing one molecule of water.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/what-do-clinical-trials-indicate-about-the-fat-burning-potential-of-aod-9604-peptide</loc>
    <lastmod>2026-07-22T03:21:40-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_what-do-clinical-trials-indi_1b59360c-4256-4b51-8f7a-ad647d9343a6.webp?v=1784699730</image:loc>
      <image:title>What Do Clinical Trials Indicate About the Fat-Burning Potential of AOD-9604 Peptide?</image:title>
      <image:caption>Qovigen research diagram</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/does-semaglutide-provide-a-sustainable-solution-for-long-term-weight-loss</loc>
    <lastmod>2026-07-22T03:21:41-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_does-semaglutide-provide-a-s.webp?v=1784693482</image:loc>
      <image:title>Does Semaglutide Provide a Sustainable Solution for Long-Term Weight Loss?</image:title>
      <image:caption>Semaglutide engages the GLP-1 receptor across central appetite, reward and peripheral pathways to lower energy intake; controlled trials show the effect reverses after withdrawal.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/how-does-tirzepatide-improve-fat-loss-and-insulin-sensitivity-in-clinical-research</loc>
    <lastmod>2026-07-22T03:21:42-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_how-does-tirzepatide-improve_7bf78ace-8e51-4586-937d-f37d07aeb067.webp?v=1784693490</image:loc>
      <image:title>How Does Tirzepatide Improve Fat Loss and Insulin Sensitivity in Clinical Research?</image:title>
      <image:caption>How tirzepatide&apos;s dual GIP and GLP-1 receptor agonism maps onto insulin-secretion, glucagon, and adipose-tissue signals reported in preclinical and clinical research.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/can-scientific-research-validate-cagrilintide-s-role-in-appetite-regulation</loc>
    <lastmod>2026-07-22T03:21:43-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_can-scientific-research-vali.webp?v=1784693613</image:loc>
      <image:title>Can Scientific Research Validate Cagrilintide’s Role in Appetite Regulation?</image:title>
      <image:caption>Schematic of how cagrilintide is proposed to engage hindbrain amylin receptors to modulate satiety and food intake in experimental models.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/how-does-retatrutide-research-inform-treatment-of-atherogenic-dyslipidemia</loc>
    <lastmod>2026-07-22T03:21:44-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_how-does-retatrutide-researc.webp?v=1784693735</image:loc>
      <image:title>How Does Retatrutide Research Inform Treatment of Atherogenic Dyslipidemia?</image:title>
      <image:caption>How retatrutide&apos;s three receptor arms are hypothesized to intersect hepatic and systemic lipid handling; solid links reflect Phase 2 or rodent data, dashed links mark contested or inferred mechanisms.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/modulation-of-fibroblast-phenotype-and-collagen-synthesis-by-ghk-cu-in-experimental-repair-models</loc>
    <lastmod>2026-07-22T03:21:45-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_modulation-of-fibroblast-phe.webp?v=1784693860</image:loc>
      <image:title>Modulation of Fibroblast Phenotype and Collagen Synthesis by GHK-Cu in Experimental Repair Models</image:title>
      <image:caption>Schematic of GHK-Cu acting as a copper carrier and transcriptional modulator that shifts fibroblasts toward organized matrix output in preclinical repair models.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/what-evidence-supports-ghk-cu-s-therapeutic-potential-in-oxidative-stress</loc>
    <lastmod>2026-07-22T03:22:03-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_what-evidence-supports-ghk-c_e8f76a55-0379-4a8f-a00e-fc9063149085.webp?v=1784699754</image:loc>
      <image:title>What Evidence Supports GHK-Cu’s Therapeutic Potential in Oxidative Stress?</image:title>
      <image:caption>Qovigen research diagram</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/what-do-studies-reveal-about-klow-peptides-and-energy-metabolism</loc>
    <lastmod>2026-07-22T03:22:04-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_what-do-studies-reveal-about.webp?v=1784693017</image:loc>
      <image:title>What Do Studies Reveal About KLOW Peptides and Energy Metabolism?</image:title>
      <image:caption>How each KLOW component connects, indirectly and by inference, to mitochondrial energy pathways in preclinical models.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/can-scientific-evaluation-uncover-glp-1-signaling-mechanisms-in-arterial-stiffness</loc>
    <lastmod>2026-07-22T03:22:05-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_can-scientific-evaluation-un.webp?v=1784693140</image:loc>
      <image:title>Can Scientific Evaluation Uncover GLP-1 Signaling Mechanisms in Arterial Stiffness?</image:title>
      <image:caption>Proposed route from GLP-1 receptor activation on the endothelium to reduced arterial wall stiffness, with the evidence level noted honestly.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/does-current-research-support-peptide-glow-in-enhancing-collagen-synthesis-pathways</loc>
    <lastmod>2026-07-22T03:22:05-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_does-current-research-suppor.webp?v=1784693263</image:loc>
      <image:title>Does Current Research Support Peptide Glow in Enhancing Collagen Synthesis Pathways?</image:title>
      <image:caption>Where GHK-Cu is reported to intersect the fibroblast collagen synthesis and turnover pathway — evidence is preclinical, and the GLOW blend itself is not clinically validated.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/can-pt-141-scientifically-improve-fatigue-and-libido-dysregulation-in-chronic-illnesses</loc>
    <lastmod>2026-07-22T03:22:07-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_can-pt-141-scientifically-im_619eb512-8fd7-416b-9a6f-6432d557f044.webp?v=1784699573</image:loc>
      <image:title>Can PT-141 Scientifically Improve Fatigue and Libido Dysregulation in Chronic Illnesses?</image:title>
      <image:caption>Qovigen research diagram</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/what-research-links-aod-9604-to-neuroprotection-in-obesity-related-cognitive-decline</loc>
    <lastmod>2026-07-22T03:22:08-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_what-research-links-aod-9604_65470446-0413-4b3a-9f92-ffd5364268e9.webp?v=1784699778</image:loc>
      <image:title>What Research Links AOD-9604 to Neuroprotection in Obesity-Related Cognitive Decline?</image:title>
      <image:caption>Qovigen research diagram</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/what-current-scientific-evidence-says-about-melanotan-ii-preventing-dermatologic-disease</loc>
    <lastmod>2026-07-22T03:22:08-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_what-current-scientific-evid_73ab90ef-deef-4be7-a606-66fa179ef924.webp?v=1784699722</image:loc>
      <image:title>What Current Scientific Evidence Says About Melanotan II Preventing Dermatologic Disease?</image:title>
      <image:caption>Qovigen research diagram</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/what-scientific-evidence-supports-peptide-nad-preserving-neurons-during-stroke</loc>
    <lastmod>2026-07-22T03:22:09-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_what-scientific-evidence-sup_cbf47c98-7e01-4c2f-9b5f-180a30edb82c.webp?v=1784693710</image:loc>
      <image:title>What Scientific Evidence Supports Peptide NAD+ Preserving Neurons During Stroke?</image:title>
      <image:caption>Simplified schematic of the PARP-1/NAD+ axis and the sirtuin arm as characterized in preclinical cerebral ischemia models; not a depiction of human treatment.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/does-current-evidence-support-tirzepatide-as-breakthrough-therapy-for-type-2-diabetes</loc>
    <lastmod>2026-07-22T03:22:10-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_does-current-evidence-suppor.webp?v=1784693836</image:loc>
      <image:title>Does Current Evidence Support Tirzepatide As Breakthrough Therapy For Type-2 Diabetes?</image:title>
      <image:caption>Tirzepatide engages the GIP and GLP-1 receptors from one peptide sequence &amp;mdash; asymmetrically &amp;mdash; with both pathways converging on cAMP to potentiate glucose-dependent insulin secretion.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/does-scientific-evidence-support-bpc-157-as-a-long-term-tendonitis-therapy</loc>
    <lastmod>2026-07-22T03:22:11-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_does-scientific-evidence-sup.webp?v=1784693953</image:loc>
      <image:title>Does Scientific Evidence Support BPC-157 as a Long-Term Tendonitis Therapy?</image:title>
      <image:caption>Proposed preclinical mechanism of BPC-157 in tendon-repair models: fibroblast signaling, angiogenesis, and collagen organization — evidence is in-vitro and rodent-only.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/does-current-research-support-cagrilintide-s-role-in-lowering-stroke-risk</loc>
    <lastmod>2026-07-22T03:21:29-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_does-current-research-suppor_6ac558ce-dc23-4863-9883-54fb17f335e5.webp?v=1784693890</image:loc>
      <image:title>Does Current Research Support Cagrilintide’s Role in Lowering Stroke Risk?</image:title>
      <image:caption>Proposed mechanistic chain under investigation: cagrilintide acts on amylin receptors to shift metabolic surrogates, with any downstream cerebrovascular effect still hypothesised rather than measured.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/what-are-the-critical-handling-protocols-for-retatrutide-research-studies</loc>
    <lastmod>2026-07-22T03:21:30-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_what-are-the-critical-handli.webp?v=1784694035</image:loc>
      <image:title>What Are the Critical Handling Protocols for Retatrutide Research Studies?</image:title>
      <image:caption>The major chemical and physical degradation routes for a lipidated peptide like retatrutide, and the handling controls each storage rule is designed to slow. Illustrative summary of the peptide-formulation literature; for research use only.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/what-evidence-supports-ghk-cu-peptide-in-preventing-copd-and-pulmonary-fibrosis</loc>
    <lastmod>2026-07-22T03:21:31-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_what-evidence-supports-ghk-c_ee1121b7-dda8-4eb1-929f-3075b32ca4fb.webp?v=1784694044</image:loc>
      <image:title>What Evidence Supports GHK-Cu Peptide in Preventing COPD and Pulmonary Fibrosis?</image:title>
      <image:caption>Proposed preclinical mechanism: GHK-Cu modulating NF-κB, TGF-β1/Smad2/3, Nrf2, and MMP-9/TIMP-1 in oxidative lung-injury models.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/what-evidence-supports-klow-peptides-in-angiogenesis-and-tissue-repair</loc>
    <lastmod>2026-07-22T03:21:31-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_what-evidence-supports-klow.webp?v=1784694159</image:loc>
      <image:title>What Evidence Supports KLOW Peptides in Angiogenesis and Tissue Repair?</image:title>
      <image:caption>Schematic of the individual signalling routes each KLOW component has been studied in, converging on angiogenesis and tissue-repair readouts in preclinical models.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/could-aod-9604-enhance-healing-in-diabetic-foot-ulcers-and-wound-repair</loc>
    <lastmod>2026-07-22T03:21:32-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_could-aod-9604-enhance-heali.webp?v=1784694273</image:loc>
      <image:title>Could AOD-9604 Enhance Healing in Diabetic Foot Ulcers and Wound Repair?</image:title>
      <image:caption>AOD-9604&apos;s documented action is adipocyte lipolysis in rodent models; any link to diabetic wound repair remains hypothesized, with no direct data.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/how-do-glp-1-pathways-regulate-lipid-metabolism-in-atherogenic-dyslipidemia</loc>
    <lastmod>2026-07-22T03:21:33-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_how-do-glp-1-pathways-regula_9a2b6ccc-74e4-42c8-9e99-09334837bd67.webp?v=1784699628</image:loc>
      <image:title>How Do GLP-1 Pathways Regulate Lipid Metabolism in Atherogenic Dyslipidemia?</image:title>
      <image:caption>Qovigen research diagram</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/does-glow-peptide-stimulate-fibroblast-activity-to-enhance-dermal-elasticity</loc>
    <lastmod>2026-07-22T03:21:34-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_does-glow-peptide-stimulate_962dcdc2-ddfd-4f14-9bf9-943a5d4bc7c6.webp?v=1784699612</image:loc>
      <image:title>Does Glow Peptide Stimulate Fibroblast Activity to Enhance Dermal Elasticity?</image:title>
      <image:caption>Qovigen research diagram</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/can-pt-141-enhance-blood-flow-in-peripheral-artery-disease-pad</loc>
    <lastmod>2026-07-22T03:21:35-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_can-pt-141-enhance-blood-flo.webp?v=1784694657</image:loc>
      <image:title>Can PT-141 Enhance Blood Flow in Peripheral Artery Disease (PAD)?</image:title>
      <image:caption>Hypothesized melanocortin-receptor signaling toward vascular tone — with the honest caveat that the direction of the nitric-oxide effect is model-dependent and PT-141 has not been tested in peripheral artery disease.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/what-evidence-supports-ghk-cu-peptide-in-preventing-copd-and-pulmonary-fibrosis-1</loc>
    <lastmod>2026-07-22T03:21:36-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_what-evidence-supports-ghk-c_edccf894-9789-493d-8c40-1e40cbb5100e.webp?v=1784699746</image:loc>
      <image:title>Can PT-141 Modulate Inflammatory Responses in Autoimmune Disorders?</image:title>
      <image:caption>Qovigen research diagram</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/can-tb-500-support-regeneration-in-spinal-cord-injuries</loc>
    <lastmod>2026-07-22T03:21:36-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_can-tb-500-support-regenerat_47b555e2-2cea-47d1-aa8f-72fb290a0929.webp?v=1784699580</image:loc>
      <image:title>Can TB-500 Support Regeneration in Spinal Cord Injuries?</image:title>
      <image:caption>Qovigen research diagram</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/how-does-melanotan-ii-influence-erectile-performance-mechanistically</loc>
    <lastmod>2026-07-22T03:22:12-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_how-does-melanotan-ii-influe_ae9d66f8-3301-4971-87e9-dba59d2af7e9.webp?v=1784699643</image:loc>
      <image:title>How Does Melanotan II Influence Erectile Performance Mechanistically?</image:title>
      <image:caption>Qovigen research diagram</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/can-bpc-157-actually-help-heal-nerves-and-boost-brain-health</loc>
    <lastmod>2026-07-22T03:22:13-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_can-bpc-157-actually-help-he.webp?v=1784694104</image:loc>
      <image:title>Can BPC-157 Actually Help Heal Nerves and Boost Brain Health?</image:title>
      <image:caption>Proposed neurovascular pathways attributed to BPC-157 in rodent studies — angiogenic (NO/VEGF/FAK) and neuroprotective signaling. Preclinical evidence only.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/can-aod-aid-recovery-from-muscle-wasting-in-cachexia-or-sarcopenia</loc>
    <lastmod>2026-07-22T03:22:14-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_can-aod-aid-recovery-from-mu.webp?v=1784694224</image:loc>
      <image:title>Can AOD Aid Recovery from Muscle Wasting in Cachexia or Sarcopenia?</image:title>
      <image:caption>AOD-9604&apos;s demonstrated action is lipolytic in adipose tissue; the proposed AMPK-mediated muscle-preservation pathway is hypothetical and untested.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/what-mechanisms-link-nad-to-dna-repair-and-cancer-prevention</loc>
    <lastmod>2026-07-22T03:22:15-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_what-mechanisms-link-nad-to.webp?v=1784694338</image:loc>
      <image:title>What Mechanisms Link NAD+ to DNA Repair and Cancer Prevention?</image:title>
      <image:caption>How NAD+ links DNA-damage sensing (PARP1) and sirtuin signaling to genome maintenance in preclinical models.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/how-safe-is-cagrilintide-use-in-patients-with-chronic-kidney-disease</loc>
    <lastmod>2026-07-22T03:22:16-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_how-safe-is-cagrilintide-use.webp?v=1784694479</image:loc>
      <image:title>How Safe Is Cagrilintide Use in Patients with Chronic Kidney Disease?</image:title>
      <image:caption>How cagrilintide is proposed to act on satiation in metabolic trials, and where the chronic kidney disease evidence remains uncharacterized.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/does-sermorelin-support-cognitive-function-in-age-related-neurodegeneration</loc>
    <lastmod>2026-07-22T03:22:16-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_does-sermorelin-support-cogn_a0b57ebb-3820-432e-8411-a78611fb9748.webp?v=1784699620</image:loc>
      <image:title>Does Sermorelin Support Cognitive Function in Age-Related Neurodegeneration?</image:title>
      <image:caption>Qovigen research diagram</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/how-does-tirzepatide-influence-incretin-pathways</loc>
    <lastmod>2026-07-22T03:22:17-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_how-does-tirzepatide-influen_aa2ad239-5c78-421a-9efa-c954ee7c3d6a.webp?v=1784699690</image:loc>
      <image:title>How Does Tirzepatide Influence Incretin Pathways?</image:title>
      <image:caption>Qovigen research diagram</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/how-does-retatrutide-fit-into-the-evolution-of-peptide-therapeutics</loc>
    <lastmod>2026-07-22T03:22:18-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_how-does-retatrutide-fit-int.webp?v=1784694872</image:loc>
      <image:title>How Does Retatrutide Fit into the Evolution of Peptide Therapeutics?</image:title>
      <image:caption>One synthetic peptide, three receptor arms: retatrutide is reported to engage GLP-1R, GIPR and GCGR at deliberately tuned relative potencies. The glucagon-receptor arm (GCGR) is the newest and least characterized in humans.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/how-does-ghk-cu-affect-hair-follicle-stem-cells-and-hair-growth</loc>
    <lastmod>2026-07-22T03:22:19-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_how-does-ghk-cu-affect-hair.webp?v=1784694984</image:loc>
      <image:title>How Does GHK-Cu Affect Hair Follicle Stem Cells and Hair Growth?</image:title>
      <image:caption>Proposed, evidence-limited routes by which the copper peptide GHK-Cu could intersect hair follicle stem cell signaling, angiogenesis, and matrix remodeling.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/is-tb-500-a-promising-therapy-for-chronic-inflammatory-conditions</loc>
    <lastmod>2026-07-22T03:22:19-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_is-tb-500-a-promising-therap.webp?v=1784695103</image:loc>
      <image:title>Is TB-500 a Promising Therapy for Chronic Inflammatory Conditions?</image:title>
      <image:caption>Simplified schematic of the two most-studied actions of thymosin beta-4 / TB-500 in inflammatory models: G-actin sequestration driving cell migration, and suppression of NF-kB signalling; the outcomes shown are preclinical.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/could-melanotan-ii-play-a-role-in-treating-hypoactive-sexual-desire-disorder</loc>
    <lastmod>2026-07-22T03:21:21-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_could-melanotan-ii-play-a-ro_76237124-ced9-44df-bdc5-21baa8bbf2e3.webp?v=1784699596</image:loc>
      <image:title>Could Melanotan II Play a Role in Treating Hypoactive Sexual Desire Disorder?</image:title>
      <image:caption>Qovigen research diagram</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/what-is-the-link-between-nad-deficiency-and-parkinson-s-progression</loc>
    <lastmod>2026-07-22T03:21:22-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_what-is-the-link-between-nad.webp?v=1784695271</image:loc>
      <image:title>What Is the Link Between NAD+ Deficiency and Parkinson’s Progression?</image:title>
      <image:caption>How increased NAD+ consumption and constrained salvage lower the neuronal NAD+ pool, distorting the NAD+/NADH ratio and impairing energy output, DNA repair, and mitophagy in Parkinson&apos;s disease models.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/can-cagrilintide-prevent-diabetes-in-high-risk-patients</loc>
    <lastmod>2026-07-22T03:21:22-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_can-cagrilintide-prevent-dia.webp?v=1784695382</image:loc>
      <image:title>Can Cagrilintide Prevent Diabetes in High-Risk Patients?</image:title>
      <image:caption>How cagrilintide&apos;s amylin-receptor actions link to weight loss and glycaemic measures, with the diabetes-prevention step shown as an untested hypothesis.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/is-bpc-157-the-missing-link-in-treating-inflammation-and-joint-pain</loc>
    <lastmod>2026-07-22T03:21:23-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_is-bpc-157-the-missing-link_2d640ea9-7f5a-4172-9109-957bed7b69be.webp?v=1784699698</image:loc>
      <image:title>Is BPC-157 the Missing Link in Treating Inflammation and Joint Pain?</image:title>
      <image:caption>Qovigen research diagram</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/what-do-the-latest-clinical-trials-reveal-about-tirzepatide</loc>
    <lastmod>2026-07-22T03:21:24-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_what-do-the-latest-clinical.webp?v=1784695648</image:loc>
      <image:title>What Do the Latest Clinical Trials Reveal About Tirzepatide?</image:title>
      <image:caption>Schematic of tirzepatide&apos;s dual GIP/GLP-1 receptor activity and the downstream signals studied in preclinical and clinical research.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/how-does-retatrutide-impact-cardiovascular-risk-factors</loc>
    <lastmod>2026-07-22T03:21:25-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_how-does-retatrutide-impact.webp?v=1784695765</image:loc>
      <image:title>How Does Retatrutide Impact Cardiovascular Risk Factors?</image:title>
      <image:caption>How retatrutide&apos;s three-receptor agonism maps to cardiometabolic risk markers reported in phase 2-3 trials, including the observed heart-rate increase and the gap between markers and outcomes.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/what-evidence-supports-tb-500-use-in-pulmonary-fibrosis-research</loc>
    <lastmod>2026-07-22T03:21:26-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_what-evidence-supports-tb-50.webp?v=1784695895</image:loc>
      <image:title>What Evidence Supports TB-500 Use in Pulmonary Fibrosis Research?</image:title>
      <image:caption>The two experimentally supported actions of thymosin β4 (TB-500): sequestering monomeric G-actin to regulate filament assembly and cell migration, and forming a PINCH–ILK complex that activates the survival kinase Akt.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/can-ghk-cu-reduce-complications-in-post-transplant-recovery</loc>
    <lastmod>2026-07-22T03:21:26-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_can-ghk-cu-reduce-complicati.webp?v=1784696011</image:loc>
      <image:title>Can GHK-Cu Reduce Complications in Post-Transplant Recovery?</image:title>
      <image:caption>Preclinical schematic: GHK-Cu signaling to fibroblast matrix remodeling and inflammatory pathways observed in cell and rodent models, with graft relevance shown as an untested hypothesis.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/what-are-the-broader-scientific-applications-of-retatrutide</loc>
    <lastmod>2026-07-22T03:21:27-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_what-are-the-broader-scienti.webp?v=1784696130</image:loc>
      <image:title>What Are the Broader Scientific Applications of Retatrutide?</image:title>
      <image:caption>Retatrutide&apos;s triple-agonist mechanism: one peptide activates GLP-1R, GIPR and GCGR, each raising cAMP, with the incretin and glucagon arms converging on complementary metabolic effects (schematic based on Coskun et al., Cell Metab 2022).</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/could-ghk-cu-improve-outcomes-in-chronic-non-healing-wounds</loc>
    <lastmod>2026-07-22T03:21:28-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_could-ghk-cu-improve-outcome_cdb5a1e9-ee76-4a0a-9e7b-171fc7544824.webp?v=1784699588</image:loc>
      <image:title>Could GHK-Cu Improve Outcomes in Chronic Non-Healing Wounds?</image:title>
      <image:caption>Qovigen research diagram</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/could-tb-500-help-patients-with-peripheral-neuropathy</loc>
    <lastmod>2026-07-22T03:20:38-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_could-tb-500-help-patients-w_617e94c1-00b1-4fcd-bfc7-437e6a43a5cf.webp?v=1784699604</image:loc>
      <image:title>Could TB-500 Help Patients with Peripheral Neuropathy?</image:title>
      <image:caption>Qovigen research diagram</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/how-does-melanotan-ii-10mg-activate-the-melanocortin-receptor-pathway</loc>
    <lastmod>2026-07-22T03:20:39-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_how-does-melanotan-ii-10mg-a.webp?v=1784696046</image:loc>
      <image:title>How Does Melanotan II (10mg) Activate the Melanocortin Receptor Pathway?</image:title>
      <image:caption>Schematic of the proposed Melanotan II signalling cascade: receptor binding couples to Gs, raising intracellular cAMP; downstream effects are characterised mainly in preclinical models.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/how-does-nad-influence-cellular-aging-and-longevity-pathways</loc>
    <lastmod>2026-07-22T03:20:40-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_how-does-nad-influence-cellu.webp?v=1784696175</image:loc>
      <image:title>How Does NAD+ Influence Cellular Aging and Longevity Pathways?</image:title>
      <image:caption>Schematic of NAD+ turnover in an aging cell: salvage-pathway recycling declines while CD38 and PARP consumption rises, lowering sirtuin activity and feeding senescence and inflammaging. Based mainly on rodent and in-vitro models.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/how-does-cagrilintide-affect-non-alcoholic-fatty-liver-disease</loc>
    <lastmod>2026-07-22T03:20:41-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_how-does-cagrilintide-affect.webp?v=1784696297</image:loc>
      <image:title>How Does Cagrilintide Affect Non-Alcoholic Fatty Liver Disease</image:title>
      <image:caption>How amylin-receptor signaling by cagrilintide is hypothesized to reach the liver, mostly indirectly through weight loss, with the direct hepatic pathway resting on preclinical rodent data only.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/does-bpc-157-show-therapeutic-potential-for-osteoarthritis-and-joint-degeneration</loc>
    <lastmod>2026-07-22T03:20:42-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_does-bpc-157-show-therapeuti.webp?v=1784696424</image:loc>
      <image:title>Does BPC-157 show therapeutic potential for osteoarthritis and joint degeneration</image:title>
      <image:caption>Mechanisms attributed to BPC-157 in preclinical joint-repair models, with the honest evidence caveat that none are confirmed in controlled human trials.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/what-are-the-pharmacodynamics-of-tirzepatide-in-scientific-studies</loc>
    <lastmod>2026-07-22T03:20:43-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_what-are-the-pharmacodynamic.webp?v=1784696541</image:loc>
      <image:title>What Are the Pharmacodynamics of Tirzepatide in Scientific Studies?</image:title>
      <image:caption>How research models tirzepatide&apos;s imbalanced, biased dual GIP/GLP-1 receptor agonism and its downstream metabolic effects.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/retatrutide-s-molecular-structure-and-its-role-in-combating-metabolic-disorders</loc>
    <lastmod>2026-07-22T03:20:44-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_retatrutide-s-molecular-stru.webp?v=1784696674</image:loc>
      <image:title>Retatrutide’s Molecular Structure and Its Role in Combating Metabolic Disorders</image:title>
      <image:caption>One engineered peptide engages three incretin and glucagon receptors, with distinct downstream signals converging on metabolic endpoints reported in preclinical and phase 2 research.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/how-does-ghk-cu-influence-skin-regeneration-and-wound-healing</loc>
    <lastmod>2026-07-22T03:20:44-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_how-does-ghk-cu-influence-sk_c9b13b00-66bf-4997-9940-24c746044dcf.webp?v=1784699636</image:loc>
      <image:title>How Does GHK-Cu Influence Skin Regeneration and Wound Healing?</image:title>
      <image:caption>Qovigen research diagram</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/can-tb-500-peptide-accelerate-healing-in-musculoskeletal-injuries</loc>
    <lastmod>2026-07-22T03:20:45-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_can-tb-500-peptide-accelerat.webp?v=1784696933</image:loc>
      <image:title>Can TB-500 Peptide Accelerate Healing in Musculoskeletal Injuries?</image:title>
      <image:caption>Proposed preclinical mechanism: thymosin beta-4 / TB-500 sequesters G-actin and is associated with cell migration, angiogenesis and survival signalling during tissue repair in animal and in-vitro models.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/why-is-tirzepatide-important-in-obesity-research</loc>
    <lastmod>2026-07-22T03:20:46-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_why-is-tirzepatide-important.webp?v=1784697046</image:loc>
      <image:title>Why Is Tirzepatide Important in Obesity Research</image:title>
      <image:caption>How tirzepatide engages both incretin receptors from a single molecule: biased, imbalanced dual agonism at the GLP-1 and GIP receptors, with downstream effects on insulin secretion, appetite signaling, and adipose handling.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/the-future-of-wellness-nad-500mg-and-its-therapeutic-potential</loc>
    <lastmod>2026-07-22T03:21:54-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_the-future-of-wellness-nad-5_556135c0-b1dd-45e0-bb3f-2420d8d8b82c.webp?v=1784699715</image:loc>
      <image:title>The Future of Wellness: NAD+ 500mg and Its Therapeutic Potential</image:title>
      <image:caption>Qovigen research diagram</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/could-cagrilintide-reset-the-brain-s-hunger-switch-for-lasting-results</loc>
    <lastmod>2026-07-22T03:21:55-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_could-cagrilintide-reset-the.webp?v=1784696921</image:loc>
      <image:title>Could Cagrilintide Reset the Brain’s “Hunger Switch” for Lasting Results?</image:title>
      <image:caption>How amylin and its analog cagrilintide are understood to engage hindbrain and hypothalamic satiation circuits; evidence is largely preclinical.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/how-might-bpc-157-revolutionize-recovery-from-sports-injuries</loc>
    <lastmod>2026-07-22T03:21:56-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_how-might-bpc-157-revolution.webp?v=1784697041</image:loc>
      <image:title>How Might BPC-157 Revolutionize Recovery from Sports Injuries?</image:title>
      <image:caption>Proposed BPC-157 repair mechanisms reported in rodent and in-vitro models: angiogenesis via VEGFR2, FAK-paxillin-linked fibroblast migration, growth-hormone-receptor upregulation, and reduced inflammatory cytokines. Preclinical evidence only.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/how-does-retatrutide-work-as-a-triple-agonist</loc>
    <lastmod>2026-07-22T03:21:56-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_how-does-retatrutide-work-as.webp?v=1784697147</image:loc>
      <image:title>How Does Retatrutide Work as a Triple Agonist?</image:title>
      <image:caption>Schematic of retatrutide&apos;s proposed triple-receptor mechanism: one peptide engaging GLP-1, GIP and glucagon receptors, with the downstream metabolic levers reported in preclinical and phase 2 research.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/the-science-behind-tirzepatide-glp-1-and-gip-dual-action</loc>
    <lastmod>2026-07-22T03:21:57-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_the-science-behind-tirzepati.webp?v=1784697269</image:loc>
      <image:title>The Science Behind Tirzepatide: GLP-1 and GIP Dual Action</image:title>
      <image:caption>Tirzepatide is a single peptide that activates both the GIP and GLP-1 receptors, with imbalanced, biased signaling converging on glucose-dependent insulin secretion.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/the-science-behind-retatrutide-a-new-hope-for-obesity-and-diabetes</loc>
    <lastmod>2026-07-22T03:21:59-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_the-science-behind-retatruti.webp?v=1784697382</image:loc>
      <image:title>The Science Behind Retatrutide: A New Hope for Obesity and Diabetes</image:title>
      <image:caption>A single retatrutide peptide engages three receptors (GLP-1, GIP, glucagon), each linked to distinct downstream metabolic signals reported in preclinical and phase 2 research.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/semaglutide-and-beyond-exploring-new-horizons-in-peptide-therapy</loc>
    <lastmod>2026-07-22T03:21:59-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_semaglutide-and-beyond-explo.webp?v=1784697491</image:loc>
      <image:title>Semaglutide and Beyond: Exploring New Horizons in Peptide Therapy</image:title>
      <image:caption>How semaglutide binds albumin for longevity, then engages GLP-1 receptors across brain, stomach, pancreas and cardiovascular tissue to reduce energy intake.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/bpc-157-uses-effects-and-safety-a-complete-guid</loc>
    <lastmod>2026-07-22T03:22:00-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_bpc-157-uses-effects-and-saf.webp?v=1784697602</image:loc>
      <image:title>BPC-157 Uses, Effects, and Safety: A Complete Guid</image:title>
      <image:caption>Proposed, preclinical-only signaling attributed to BPC-157 in animal and in-vitro models, converging on tissue-repair readouts.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/from-exhaustion-to-energy-the-power-of-nad-for-better-health</loc>
    <lastmod>2026-07-22T03:22:01-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_from-exhaustion-to-energy-th.webp?v=1784697720</image:loc>
      <image:title>From Exhaustion to Energy:  The Power of NAD+ for Better Health</image:title>
      <image:caption>The cellular NAD+ economy: parallel synthesis routes replenish NAD+, while sirtuins, PARPs and CD38 consume it — a balance that tilts toward depletion with age in preclinical models.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/the-science-behind-tb-500-accelerating-wound-healing-and-repair</loc>
    <lastmod>2026-07-22T03:22:02-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_the-science-behind-tb-500-ac.webp?v=1784697842</image:loc>
      <image:title>The Science Behind TB-500: Accelerating Wound Healing and Repair</image:title>
      <image:caption>How thymosin beta-4 / TB-500 is studied: actin binding to cell migration to downstream tissue responses, with an honest note that most evidence is preclinical.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/the-science-behind-ghk-cu-s-role-in-wound-healing-and-inflammation</loc>
    <lastmod>2026-07-22T03:21:12-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_the-science-behind-ghk-cu-s.webp?v=1784698022</image:loc>
      <image:title>The Science Behind GHK-Cu’s Role in Wound Healing and Inflammation</image:title>
      <image:caption>Schematic of GHK chelating copper(II) to form GHK-Cu, and the copper-dependent processes reported across preclinical models: matrix crosslinking via lysyl oxidase, antioxidant support via superoxide dismutase, and angiogenesis.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/what-is-melanotan-ii-and-how-does-it-affect-skin-pigmentation</loc>
    <lastmod>2026-07-22T03:21:13-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_what-is-melanotan-ii-and-how.webp?v=1784698155</image:loc>
      <image:title>What Is Melanotan II and How Does It Affect Skin Pigmentation?</image:title>
      <image:caption>Simplified MC1R signalling cascade: a melanocortin agonist raises cAMP and PKA activity, driving MITF-dependent tyrosinase expression and eumelanin synthesis, with a branch to DNA-repair signalling seen in cell models.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/how-does-tirzepatide-work-as-a-dual-glp-1-and-gip-agonist</loc>
    <lastmod>2026-07-22T03:21:14-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_how-does-tirzepatide-work-as.webp?v=1784698276</image:loc>
      <image:title>How Does Tirzepatide Work as a Dual GLP-1 and GIP Agonist?</image:title>
      <image:caption>Tirzepatide is a single peptide that engages both the GIP and GLP-1 receptors on the beta cell, with stronger, imbalanced activity at the GIP receptor and biased signalling at the GLP-1 receptor (cell and rodent data).</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://qovigen.com/blogs/news/the-future-of-obesity-treatment-exploring-cagrilintide-s-potential</loc>
    <lastmod>2026-07-22T03:21:15-04:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/0777/1029/5267/articles/fig_the-future-of-obesity-treatm.webp?v=1784698390</image:loc>
      <image:title>The Future of Obesity Treatment: Exploring Cagrilintide’s Potential</image:title>
      <image:caption>Simplified amylin-receptor satiety pathway engaged by cagrilintide; receptor-level detail is drawn largely from rodent and in-vitro models.</image:caption>
    </image:image>
  </url>
</urlset>
